I
RYTM icon

InceptionR’s Rhythm Pharmaceuticals RYTM Stock Holding History

InceptionR’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$381K Buy
+4,379
New +$426K 0.09% 405
2025
Q4 		– Sell
-7,482
Closed -$756K – 841
2025
Q3 		$756K Buy
+7,482
New +$695K 0.18% 196

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

InceptionR's RYTM Position: Q1 2026 in Review

InceptionR opened a new position in Rhythm Pharmaceuticals (RYTM) in Q1 2026: 4,379 shares worth $381K. The stake represents 0.09% of the portfolio and ranks #405 among its holdings. This is a return to the name: InceptionR previously reported a position in RYTM as recently as Q3 2025.

InceptionR first reported a position in RYTM in Q3 2025 and has held it in 2 quarters since. The position peaked at $756K in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • InceptionR held 4,379 shares of Rhythm Pharmaceuticals worth $381K as of Q1 2026.
  • Rhythm Pharmaceuticals was a new InceptionR position in Q1 2026.
  • Rhythm Pharmaceuticals made up 0.09% of InceptionR's portfolio in Q1 2026, its #405 holding.
  • InceptionR first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • InceptionR's Rhythm Pharmaceuticals position peaked at $756K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.